SCHEMBL4305149

SCHEMBL4305149

O=C(N1CCCCC1)N1CCOCC1

nearest known ligand 0.95

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.82
KMT2A Q03164 2/20 0.82
TP53 P04637 1/20 0.82
ALDH1A1 P00352 3/20 0.67
SMN1; SMN2 Q16637 2/20 0.55
MAPT P10636 1/20 0.55
CA2 P00918 1/20 0.54
CHKA P35790 1/20 0.54
AKR1C3 P42330 2/20 0.53
RECQL P46063 1/20 0.52
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
POLB P06746 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA9 Q16790 1/20 0.50
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2202342 1.00 MEN1 (0.82) MEN1KMT2ATP53ALDH1A1SMN1; SMN2
SCHEMBL3954355 0.97 MEN1 (0.86) MEN1KMT2ATP53ALDH1A1SMN1; SMN2
SCHEMBL30677423 0.92 MEN1 (0.95) MEN1KMT2ATP53ALDH1A1SMN1; SMN2
SCHEMBL27794130 0.90 MEN1 (0.82) MEN1KMT2ATP53ALDH1A1SMN1; SMN2
SCHEMBL2899860 0.89 MEN1 (0.80) MEN1KMT2ATP53SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL28000052 0.87 MEN1 (0.76) MEN1KMT2ATP53SMN1; SMN2MAPT
SCHEMBL11741744 0.87 MEN1 (0.85) MEN1KMT2ATP53SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL27660773 0.87 MEN1 (0.76) MEN1KMT2ATP53SMN1; SMN2MAPT
SCHEMBL8674256 0.85 MEN1 (0.60) MEN1KMT2ATP53ALDH1A1SMN1; SMN2
SCHEMBL2323473 0.84 ALDH1A1 (0.93) MEN1KMT2ATP53ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270443-A1 1-AMINO IMIDAZO-CONTAINING COMPOUNDS AND METHODS COLEY PHARMACEUTICAL GROUP, INC. 2009-10-29 US disclosed
US-7186710-B2 Phthalazinones ALTANA PHARMA AG (DE) 2007-03-06 US disclosed
US-20040127707-A1 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders ALTANA PHARMA AG (DE) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127707-A1 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders PDE4A, PDE4B, PDE7B MEN1 2426/4885KMT2A 3900/4885TP53 4268/4885
US-20090270443-A1 1-AMINO IMIDAZO-CONTAINING COMPOUNDS AND METHODS IL2, IL4I1, IFNG MEN1 2721/4885KMT2A 3187/4885TP53 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.